Delving into the Latest Updates on FMP-010 vaccine(Walter Reed Army Institute of Research) with Synapse

Overview

Drug Type

Therapeutic vaccine, Genetically engineered subunit vaccine

Synonyms

FMP 010 vaccine

Target-

Mechanism

Immunostimulants

Therapeutic Areas

Active Indication-

Inactive Indication

Originator Organization

Active Organization-

Inactive Organization

Drug Highest PhasePendingPhase 1

First Approval Date-

Regulation-

Login to view timeline

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Malaria	Phase 1	-	GSK Plc	01 Apr 2008
Malaria	Phase 1	-	Walter Reed Army Institute of Research	01 Apr 2008
Malaria, Falciparum	Phase 1	KE	GSK Plc	01 Apr 2008
Malaria, Falciparum	Phase 1	US	GSK Plc	01 Apr 2008
Malaria, Falciparum	Phase 1	US	Walter Reed Army Institute of Research	01 Apr 2008
Malaria, Falciparum	Phase 1	KE	Walter Reed Army Institute of Research	01 Apr 2008

Login to view more data

Indication

Phase

Evaluation

View All Results

Study	Phase	Population	Analyzed Enrollment	Group	Results	Evaluation	Publication Date


NCT02458092 (CTgov)	Phase 1	Malaria	30	Rabipur (Rabies Vaccine Rabipur)	ckrjjzqegy(hcleeghuqx) = srbxadcyjb zrbxtskbdg (jmlkwkuxxj, prudbbjrvz - kjsxvfannb) View more	-	09 Jun 2020
				Plasmodium falciparum Malaria Protein 010 (FMP010) (50 µg of FMP010 Antigen in 0.5 mL AS01B Adjuvant)	vdvgucujrd(mrashxybjz) = fskzbkqabd mpeudnpgoo (chhmaajjnr, zugixigakm - ywvsfzebbn) View more